Department of Economic & Community Development Commissioner Daniel O'Keefe speaks at the BioCT legislative breakfast in New ...

While vacancy rates remain high across the region's life sciences hubs, recent leasing activity and a slowdown in new ...

The industry has learned how the ball bounces—now it must decide where to play next.  | While 2025 was dedicated to “understanding a little bit more about the rules of this game that we’re playing,” ...

For biotech companies the past two years have been challenging. Biotech investments have not reached the record levels of ...

A D.C.-area biotech just hit the scene with a clear mission: change the way cancers are diagnosed and treated.

Now, it’s worth noting Stock Advisor’s total average return is 949 % — a market-crushing outperformance compared to 195% for ...

The ex-CytoDyn chief exec must also forfeit more than $4.4 million—approximately the amount he profited from the scheme—and ...

Amid a rebound in SPAC activity, the prolific “crossover” investor is aiming for its third blank-check merger since 2022 ...

Morning! Today, we see a new synthetic biology startup, backed by Frances Arnold and Bob Langer. Plus, it’s still early, but ...

From Adelaide to San Francisco, the biotechnology landscape is shifting – and, in some cases, straining under the weight of ...

SUNY Upstate Medical Center’s CNY Biotech Accelerator in Syracuse is receiving funding for major site renovations.

Biotech stocks are in focus as analysts track upcoming clinical data and regulatory decisions in autoimmune and rare disease ...